News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,135 Results
Type
Article (85253)
Company Profile (622)
Press Release (738260)
Section
Business (231829)
Career Advice (4090)
Deals (39621)
Drug Delivery (106)
Drug Development (90416)
Employer Resources (192)
FDA (17878)
Job Trends (17246)
News (394564)
Policy (39583)
Tag
Academia (2973)
Africa (1262)
Alliances (56326)
Alzheimer's disease (1241)
Approvals (17792)
Arizona (209)
Artificial intelligence (85)
Asia (48986)
Australia (8614)
Bankruptcy (392)
Best Places to Work (12244)
Biotechnology (436)
C2C Services and Suppliers (95129)
California (1959)
Canada (926)
Cancer (496)
Career advice (3497)
Cell therapy (140)
China (150)
Clinical research (70371)
Collaboration (147)
Colorado (80)
Compensation (79)
Connecticut (80)
COVID-19 (2753)
Cystic fibrosis (77)
Data (281)
Diabetes (89)
Diagnostics (6496)
Drug pricing (81)
Earnings (93516)
Employer resources (162)
Europe (111966)
Events (124946)
Executive appointments (147)
FDA (18089)
Florida (265)
Funding (144)
Gene therapy (105)
GLP-1 (615)
Government (5004)
Healthcare (20646)
Hotbed/Location (534624)
Illinois (315)
Indiana (159)
Infectious disease (2783)
Inflammatory bowel disease (101)
Interviews (805)
IPO (17482)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (467)
Legal (10011)
Lung cancer (114)
Manufacturing (98)
Maryland (421)
Massachusetts (1674)
Medical device (14257)
Medtech (14262)
Mergers & acquisitions (21950)
Metabolic disorders (291)
Michigan (135)
Minnesota (235)
Neuroscience (1400)
New Jersey (592)
New York (598)
NextGen Class of 2024 (7622)
Non-profit (5052)
North Carolina (695)
Northern California (826)
Obesity (173)
Ohio (110)
Opinion (234)
Patents (74)
Pennsylvania (585)
People (63690)
Pharmaceutical (119)
Phase I (21608)
Phase II (30551)
Phase III (23085)
Pipeline (106)
Podcasts (75)
Postmarket research (3532)
Preclinical (9761)
Press Release (72)
Rare diseases (140)
Real estate (7361)
Recruiting (72)
Regulatory (25582)
Research institute (2633)
Resumes & cover letters (645)
South America (1640)
Southern California (748)
Startups (4271)
Texas (252)
United States (9133)
Vaccines (561)
Washington State (275)
Weight loss (165)
Date
Today (77)
Last 7 days (728)
Last 30 days (2250)
Last 365 days (39991)
2024 (27797)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,135 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ESMO 2024 Late-Breaking Data: Phase III ARANOTE Trial Shows NUBEQA® (darolutamide) Significantly Reduced Risk of Radiological Progression or Death in Metastatic Hormone-Sensitive Prostate Cancer
September 16, 2024
·
14 min read
Press Releases
Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
September 16, 2024
·
5 min read
Press Releases
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
September 16, 2024
·
10 min read
Press Releases
Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer
September 16, 2024
·
7 min read
Press Releases
PatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder populations in inflammatory bowel disease
September 16, 2024
·
3 min read
Press Releases
Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011)
September 16, 2024
·
4 min read
Press Releases
Novartis Kisqali® shows deepening benefit in new analysis, reducing the risk of recurrence by 28.5% in a broad population of patients with early breast cancer
September 16, 2024
·
14 min read
Press Releases
Akeso’s Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
September 16, 2024
·
2 min read
Press Releases
Kronos Advanced Technologies, Inc. (OTC: KNOS) Announces Ex-Dividend Date for Upcoming Special Cash Dividend
September 16, 2024
·
8 min read
Press Releases
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
September 16, 2024
·
7 min read
1 of 82,414
Next
